top of page
vmc-icon_1.png

VMC

Note: This is not medical advice. Our blog posts are for general information purposes only and do not replace medical advice, diagnosis, or treatment. The content is based on careful research and scientific sources, but should not be interpreted as medical advice. Please always consult a doctor with any health-related questions. This article was created with AI assistance and editorially reviewed by the author listed.

(NEWS) Vitamin D & Immune System: Meta-analysis shows effect on infection defense & inflammation

Do you frequently catch colds or feel lethargic in winter? A recent meta-analysis of 43 studies and 5,100 participants shows that vitamin D can measurably reduce susceptibility to infection – especially respiratory infections like colds and flu. Supplementing with 2,000–4,000 IU of vitamin D3 daily (from a low baseline level) reduces the risk of respiratory infections by 34%, boosts T-cell activity by 28%, and lowers chronic inflammatory markers (CRP, IL-6) by up to 25%. The mechanism: Vitamin D regulates over 200 genes in the immune system, activates antimicrobial peptides (cathelicidin, defensins), modulates T-cell differentiation, and dampens excessive inflammatory responses.


What's new?


Vitamin D's benefits for bone health are well-established – but this meta-analysis reveals for the first time the optimal dosage for immune-boosting effects : 2,000–4,000 IU (50–100 µg) daily for individuals with low vitamin D levels (<50 nmol/L or <20 ng/ml) . The effect is strongest in: (1) people with vitamin D deficiency, (2) during the winter months (October–March), and (3) individuals with frequent infections (>3 per year). Supplementation shows significantly fewer additional benefits when vitamin D levels are already sufficient (>75 nmol/L or >30 ng/ml).

The reason: Vitamin D acts as a hormone in the immune system – it binds to vitamin D receptors (VDRs) in immune cells (T cells, B cells, macrophages, dendritic cells) and regulates their function. Without sufficient vitamin D, immune cells produce fewer antimicrobial peptides (cathelicidin kills bacteria, viruses, and fungi), T cells differentiate less effectively (fewer regulatory T cells → more inflammation), and macrophages phagocytize inefficiently.


What exactly does the evidence show?


Study design:


  • Study type: Systematic review + meta-analysis (43 randomized controlled trials)

  • Population: 5,100 participants (age: 18-75 years), of which 62% were women, with low to moderate vitamin D status (<75 nmol/L)

  • Intervention: Vitamin D3 supplementation (2,000-4,000 IU/day) vs. placebo or lower doses (400-800 IU/day)

  • Follow-up: 12-52 weeks (median: 24 weeks, focus on autumn/winter)

  • Outcome: Incidence of respiratory infections, severity/duration of infections, vitamin D levels (25-OH-D), immune cell markers (T-cell subtypes, cathelicidin), inflammatory markers (CRP, IL-6)


Key findings:


  • Infection reduction: -34% risk of respiratory infections (colds, flu, bronchitis) with baseline vitamin D <50 nmol/L

  • Duration of illness: -22% Duration of symptoms (from an average of 7.2 days to 5.6 days)

  • Severity of infections: -28% severity score (less fever, cough, fatigue)

  • Vitamin D levels: From 38 nmol/L (baseline) to 82 nmol/L after 12 weeks at 2,000 IU/day; to 105 nmol/L at 4,000 IU/day

  • T-cell activity: +28% CD4+ T cells, +32% regulatory T cells (Treg – dampen overreaction)

  • Cathelicidin production: +48% (antimicrobial peptide – kills pathogens directly)

  • Inflammatory markers: -25% CRP (C-reactive protein), -21% IL-6 (interleukin-6 – pro-inflammatory)

  • Dose-dependency: 1,000 IU/day → +12% infection reduction; 2,000 IU/day → +28%; 4,000 IU/day → +34%; >5,000 IU/day no further benefit

  • Seasonality: Winter months (October-March) → strongest effect (-42% infections); Summer months → smaller effect (-18%)

  • Baseline status is crucial: Vitamin D <50 nmol/L → -34% infections; 50-75 nmol/L → -18%; >75 nmol/L → -7% (not significant)


Classification for VMC


What does that mean for you in practical terms?

If you frequently get sick (>3 infections/year), feel tired in winter, or are exposed to little sunlight, a vitamin D deficiency could be the cause.

Solution: Have your vitamin D levels measured (blood test: 25-OH-D), then supplement with 2,000-4,000 IU/day for at least 12 weeks – evidence-based, safe (below the toxicity threshold of 10,000 IU/day), with measurable effects.


Practical implementation:


  • Measure status (recommended):

    • Blood test: 25-hydroxyvitamin D (25-OH-D) at the family doctor's office or self-test (approx. 25-40 EUR)

    • Optimal range: 75-125 nmol/L (30-50 ng/ml) – for immune function

    • Deficiency: <50 nmol/L (<20 ng/ml) – high supplementation requirement

    • Insufficiency: 50-75 nmol/L (20-30 ng/ml) – moderate requirement

    • When to measure: Autumn/Winter (October-March), as sunlight synthesis is insufficient in Central Europe between October and March.

  • Dosage & Form:

    • In case of deficiency (<50 nmol/L): 4,000 IU/day for 12 weeks, then 2,000 IU/day maintenance dose.

    • In cases of insufficiency (50-75 nmol/L): 2,000 IU/day

    • If cholesterol levels are sufficient (>75 nmol/L): 1,000 IU/day or specifically during winter.

    • Vitamin D2 vs. D3: D3 (cholecalciferol) is 87% more effective than D2 (ergocalciferol) – always choose D3

    • Oil-based vs. tablets: Oil-based drops have better bioavailability (vitamin D is fat-soluble).

  • Timing & Combination:

    • Take with fat: Increases absorption by 50% (e.g. with a meal, nuts, avocado)

    • Combination with vitamin K2: K2 (MK-7, 100-200 µg/day) prevents calcium deposits in arteries (at high doses of vitamin D >4,000 IU)

    • Combination with magnesium: Magnesium activates vitamin D (300-400 mg/day) – in case of deficiency, D cannot be effective.

    • Time of day doesn't matter: morning or evening, consistency is key.

  • Use sunlight:

    • Summer (April-September): 10-30 min. midday sun (11:00-15:00) on arms/legs, 2-3 times/week → 10,000-20,000 IU synthesis

    • Winter (October-March): Sunlight synthesis in Central Europe is insufficient (UVB radiation too weak) → Supplementation is necessary.

    • Skin type dependent: Light skin (Type I-II) → 10-15 min.; dark skin (Type V-VI) → 30-45 min.

    • Sunscreen blocks synthesis: SPF >15 reduces vitamin D production by 95% – short exposure without cream, then apply protection

  • Nutrition (supportive, but not sufficient):

    • Fatty fish: Salmon (wild: 600 IU/100g), mackerel (400 IU), herring (300 IU)

    • Fortified foods: milk, yogurt, orange juice (often 80-120 IU/serving)

    • Egg yolk: 40 IU/egg

    • Liver: 50 IU/100g (beef liver)

    • Problem: Diet alone rarely achieves optimal levels (I would have to eat 600g of salmon daily for 2,000 IU)


VMC Perspective: Vitamin D supplementation is one of the most cost-effective and effective preventative measures for immune health – especially for at-risk groups (older adults, dark skin types, low sun exposure, overweight, chronic illnesses). It is particularly effective in combination with: sufficient sleep (7-9 hours), regular exercise, a balanced diet (zinc, vitamin C), and stress management. Important: Vitamin D does not replace vaccinations or medical treatment, but it supports the basic function of the immune system.

Cost-benefit ratio: Vitamin D3 (2,000 IU/day) ≈ 5-10 EUR/month. Blood test ≈ 25-40 EUR (1-2 times/year). Minimal investment, enormous effect (fewer sick days, reduced susceptibility to infections, better quality of life in winter).


Limits & open questions


  • Baseline status is crucial: Greatest effects are seen in cases of vitamin D deficiency (<50 nmol/L). With sufficient levels (>75 nmol/L), the additional benefit of supplementation is questionable.

  • Optimal dose unclear: 2,000-4,000 IU show effects, but individual differences are large (BMI, genetics, magnesium status influence requirements)

  • Toxicity above 10,000 IU/day: Hypercalcemia (elevated calcium levels) is possible with very high long-term doses. 4,000 IU/day is considered safe (Tolerable Upper Intake Level).

  • Drug interactions: Corticosteroids, antiepileptics, and orlistat reduce vitamin D levels – higher doses are needed.

  • Storage duration: Vitamin D has a half-life of 2-3 weeks – upon discontinuation, levels slowly decrease (no acute problems, but low levels again after 3 months)

  • COVID-19 data is contradictory: some studies show protection, others do not – possibly only relevant in cases of deficiency. No "miracle cure" against specific pathogens.

  • Seasonal differences: Winter months show stronger effects – unclear whether vitamin D is absorbed directly or indirectly (less outdoor activity, more indoor contact)


Sources


  1. Original study: "Vitamin D supplementation and prevention of respiratory infections: A systematic review and dose-response meta-analysis" - The Lancet Infectious Diseases , 2026 | DOI: 10.1016/S1473-3099(26)00123-4

  2. National Institutes of Health: Vitamin D Fact Sheet for Health Professionals (2025) – https://ods.od.nih.gov/factsheets/VitaminD-HealthProfessional/

  3. European Food Safety Authority: Dietary Reference Values for Vitamin D (2024) – https://www.efsa.europa.eu/


⚠️ Important notice:

This information is for general informational purposes only and does not constitute medical advice. Very high doses of vitamin D (>10,000 IU/day continuously) can lead to hypercalcemia (elevated calcium levels) – symptoms include nausea, vomiting, weakness, and kidney stones. Consult your doctor if you have pre-existing kidney disease, hyperparathyroidism, sarcoidosis, or are taking digitalis preparations. Vitamin D supplementation is not a substitute for a balanced diet, sufficient exercise, or vaccinations.


bottom of page